Event Type
Disclosure
Voluntary
Variant
8-K
Regulation FD Disclosure. On June 16, 2025, Onconetix, Inc. (the “Company”) issued a press release announcing that it received a decision from the Nasdaq Hearin
Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed or furnished, as applicable, with this Current Report on Form 8-K: Exhibi